XP (FRA:XP9) Research & Development: €0 Mil (TTM As of Mar. 2026)


FRA:XP9 XP Inc FRA:XP9
68 GF Score
Price €13.87
GF Value €29.01
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is XP Research & Development?

XP FRA:XP9 +1.30% 68 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:XP9 with a GF Score™ of 68/100 and a GF Value™ of €29.01 (Possible Value Trap). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. XP's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

XP  (FRA:XP9) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

XP Research & Development Related Terms

XP Research & Development Historical Data

* Premium members only.

The historical data trend for XP's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XP Research & Development Chart

XP Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XP Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:XP9
68GF Score
XP Inc FRA:XP9
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XP Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
XP (FRA:XP9) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on XP and its competitors.
Is XP's Research & Development too high?
XP's current Research & Development is €0 Mil. Overall, XP has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does XP's Research & Development compare to SNEX and FIGR?
XP's Research & Development of €0 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on XP and its competitors. XP's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XP stock overvalued right now?
Based on GuruFocus' analysis, XP (FRA:XP9) is currently considered Possible Value Trap. The stock's GF Value™ is €29.01, compared to a current price of €13.87 — trading 52.2% below its estimated fair value. The current Research & Development is €0 Mil. XP's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For XP (FRA:XP9), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XP (FRA:XP9) Overvalued in 2026?

Based on GuruFocus' analysis, XP stock appears to be undervalued. The current stock price of €13.87 is trading 52.2% below its estimated GF Value™ of €29.01. GuruFocus considers XP to be Possible Value Trap.

Key valuation signals for FRA:XP9:

  • Research & Development: €0 Mil
  • GF Value™: €29.01 vs. price of €13.87 (52.2% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the FRA:XP9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XP Business Description

Address 20, Genesis Close, George Town, Vila Olimpia, Grand Cayman, CYM, KY-1-1208
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.
68GF Score

Get the complete analysis for FRA:XP9

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.87
Price
€29.01
GF Value